Literature DB >> 23939890

Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.

Ken Shimuta1, Magnus Unemo, Shu-Ichi Nakayama, Tomoko Morita-Ishihara, Misato Dorin, Takuya Kawahata, Makoto Ohnishi.   

Abstract

In 2009, the first high-level ceftriaxone-resistant Neisseria gonorrhoeae strain (H041) was isolated in Kyoto, Japan. The present study describes an intensified surveillance (antimicrobial resistance and molecular typing) of Neisseria gonorrhoeae isolates in Kyoto and its neighboring prefecture Osaka, Japan, in 2010 to 2012, which was initiated after the identification of H041. From April 2010 to March 2012, 193 N. gonorrhoeae isolates were collected and the MICs (μg/ml) to six antimicrobials, including ceftriaxone, were determined. All isolates showed susceptibility to ceftriaxone and cefixime (MIC values, <0.5 μg/ml), and spectinomycin. The rates of resistance (intermediate susceptibility) to azithromycin, penicillin G, and ciprofloxacin were 3.6% (19.7%), 24.4% (71.0%), and 78.2% (0.5%), respectively. Multilocus sequence typing (MLST) showed that 40.9%, 19.2%, and 17.1% of isolates belonged to ST1901, ST7359, and ST7363, respectively. Furthermore, N. gonorrhoeae multiantigen sequence typing (NG-MAST) revealed that 12 (63%) of the 19 isolates with decreased susceptibility to ceftriaxone (MIC > 0.064 μg/ml) were of ST1407. NG-MAST ST1407 was also the most prevalent ST (16.1%; 31 of 193 isolates). In those NG-MAST ST1407 strains, several mosaic type penA alleles were found, including SF-A type (penicillin binding protein 2 allele XXXIV) and its derivatives. These were confirmed using transformation of the penA mosaic alleles as critical determinants for enhanced cefixime and ceftriaxone MICs. The intensified surveillance in Kyoto and Osaka, Japan, did not identify any dissemination of the high-level ceftriaxone-resistant N. gonorrhoeae strain H041, suggesting that H041 might have caused only a sporadic case and has not spread further.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23939890      PMCID: PMC3811299          DOI: 10.1128/AAC.01295-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  The European gonococcal antimicrobial surveillance programme, 2009.

Authors:  M J Cole; M Unemo; S Hoffmann; S A Chisholm; C A Ison; M J van de Laar
Journal:  Euro Surveill       Date:  2011-10-20

Review 2.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

3.  Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Authors:  C A Ison; J Hussey; K N Sankar; J Evans; S Alexander
Journal:  Euro Surveill       Date:  2011-04-07

4.  The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.

Authors:  Francis Ndowa; Manjula Lusti-Narasimhan; Magnus Unemo
Journal:  Sex Transm Infect       Date:  2012-08       Impact factor: 3.519

5.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.

Authors:  Vanessa G Allen; Leo Mitterni; Christine Seah; Anuradha Rebbapragada; Irene E Martin; Colin Lee; Heather Siebert; Lynn Towns; Roberto G Melano; Donald E Low
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

6.  Gonococcal resistance: are cephalosporins next?

Authors:  Robert D Kirkcaldy; Ronald C Ballard; Deborah Dowell
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

7.  Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Authors:  David A Lewis; Charlotte Sriruttan; Etienne E Müller; Daniel Golparian; Lindy Gumede; Donald Fick; Johan de Wet; Venessa Maseko; Jennifer Coetzee; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2013-02-14       Impact factor: 5.790

8.  High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Authors:  Magnus Unemo; Daniel Golparian; Robert Nicholas; Makoto Ohnishi; Anne Gallay; Patrice Sednaoui
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

9.  Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.

Authors:  M Unemo; D Golparian; A Hestner
Journal:  Euro Surveill       Date:  2011-02-10

10.  Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.

Authors:  Makoto Ohnishi; Takeshi Saika; Shinji Hoshina; Kazuhiro Iwasaku; Shu-ichi Nakayama; Haruo Watanabe; Jo Kitawaki
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more
  38 in total

Review 1.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  penA, ponA, porB1, and mtrR Mutations and Molecular Epidemiological Typing of Neisseria gonorrhoeae with Decreased Susceptibility to Cephalosporins.

Authors:  Kayo Osawa; Katsumi Shigemura; Yukie Nukata; Koichi Kitagawa; Fukashi Yamamichi; Hiroyuki Yoshida; Toshiro Shirakawa; Soichi Arakawa; Masato Fujisawa
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 3.  Neisseria gonorrhoeae Antimicrobial Resistance: Past to Present to Future.

Authors:  Georgina L Aitolo; Oluyomi S Adeyemi; Boluwatife L Afolabi; Akinyomade O Owolabi
Journal:  Curr Microbiol       Date:  2021-02-02       Impact factor: 2.188

4.  Novel Genes Related to Ceftriaxone Resistance Found among Ceftriaxone-Resistant Neisseria gonorrhoeae Strains Selected In Vitro.

Authors:  Zijian Gong; Wei Lai; Min Liu; Zhengshuang Hua; Yayin Sun; Qingfang Xu; Yue Xia; Yue Zhao; Xiaoyuan Xie
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.

Authors:  Walter Demczuk; Tarah Lynch; Irene Martin; Gary Van Domselaar; Morag Graham; Amrita Bharat; Vanessa Allen; Linda Hoang; Brigitte Lefebvre; Greg Tyrrell; Greg Horsman; David Haldane; Richard Garceau; John Wylie; Tom Wong; Michael R Mulvey
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

6.  Susceptibility to ceftriaxone and occurrence of penicillinase plasmids in Neisseria gonorrhoeae strains isolated in Poland in 2012-2013.

Authors:  Beata Mlynarczyk-Bonikowska; Marlena Kujawa; Grazyna Mlynarczyk; Magdalena Malejczyk; Slawomir Majewski
Journal:  Folia Microbiol (Praha)       Date:  2015-11-23       Impact factor: 2.099

7.  Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.

Authors:  Claire de Curraize; Sylvain Kumanski; Maïté Micaëlo; Nelly Fournet; Guy La Ruche; Fabienne Meunier; Rishma Amarsy; Hervé Jacquier; Emmanuelle Cambau; Agathe Goubard; Béatrice Bercot
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae.

Authors:  Richard A Alm; Sushmita D Lahiri; Amy Kutschke; Linda G Otterson; Robert E McLaughlin; James D Whiteaker; Lisa A Lewis; Xiaohong Su; Michael D Huband; Humphrey Gardner; John P Mueller
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

Review 9.  Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.

Authors:  Magnus Unemo; Carlos Del Rio; William M Shafer
Journal:  Microbiol Spectr       Date:  2016-06

10.  Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics.

Authors:  Karrera Y Djoko; Maira M Goytia; Paul S Donnelly; Mark A Schembri; William M Shafer; Alastair G McEwan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.